Compass Therapeutics
Price & Volume
Stats
See moreOpen | $0.77 |
Previous Close | $0.75 |
Day Range | $0.76-$0.79 |
52W Range | $0.73-$6.88 |
Market Cap | $138.2M |
Shares Short | 41M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.39 |
News
See moreYahoo Finance • 2 days ago
Compass Therapeutics to Participate in Upcoming November Investor Events
Yahoo Finance • 21 days ago
Compass Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • last month
Microsoft upgraded, HubSpot initiated: Wall Street's top analyst calls
Yahoo Finance • last month
Compass Therapeutics Craters, FDA Pushes Survival-Trial Demand for Cancer Drug
About
CEO | Dr. Thomas J. Schuetz M.D., Ph.D. |
Address | 80 Guest Street, Boston, MA, United States, 02135 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 39 |